The bloating associated with Ozempic is primarily attributed to its mechanism of slowing gastric emptying
09.02.25 MDL numbers grew leading into September There were 2,676 pending actions in the Ozempic MDL
Excess adipose tissue can: Compress lymphatic vessels Increase inflammation Reduce lymphatic pumping efficiency Increase lymphatic fluid production Impair immune function Over time, these changes can overwhelm the lymphatic system and contribute to chronic swelling
Limit excess sodium, added sugar, and saturated (bad) fats, which can lead to heart issues, poor blood sugar control, and worsen gastrointestinal side effects of semaglutide, like bloating and abdominal pain
A new option called orforglipron, a nonpeptide oral GLP-1, may be available in 2026